Given that our work reveals GR signaling in cancer cells as a tumor-intrinsic mechanism of immune escape, further studies could help determine whether targeting GR sensitizes pancreatic cancer to chemotherapies through immune regulation. This evidence concerns the gene NR3C1 and pancreatic neoplasm.